TB

Patient Champion Spotlight: Dr. Maria José Pires Machai

During the 2019 World Health Assembly (WHA) in Geneva, Global Health Council provided several patient champions with the opportunity to share their stories, and contribute to discussions around universal health coverage (UHC). Following the Assembly, we sat down with each patient champion to get their thoughts on WHA. Hear from our patient champion Dr. Maria…

Read More

Why We’re Still Fighting One of the World’s Most Ancient Diseases

  Tuberculosis (TB) may be an ancient disease, but it is still the leading cause of infectious death worldwide, affecting more than 10 million people and killing 1.6 million in 2017 alone. Last year, the UN held the first High-Level Meeting on TB. As part of that meeting’s final political declaration, member states committed to…

Read More

Accelerating the Development of a Pathbreaking Universal Drug Regimen for TB

“Hi! My name is mycobacterium tuberculosis (MT for short). I traveled here from Washington, D.C. to attend the World Health Assembly. I’m a global killer that knows no boundaries. However, with better drugs, the Center for Global Development (CGD) wants to make me a rare collectible.” Last year’s high-level political declaration on the fight against…

Read More

#UNGA73: Making the UN Relevant to all People

This post was written by Victoria Rodriguez, Advocacy Associate at Global Health Council. This year marked the 73rd session of the UN General Assembly (UNGA). UNGA73 focused on making the UN relevant to all people through shared responsibilities for peaceful and equitable global leadership. In conjunction, the third high-level meeting (HLM) on noncommunicable diseases (NCDs)…

Read More

Investing in TB Research: World Leaders Urged to Commit to End TB

This blog post was written by the Communications Team at the Global Alliance for TB Drug Development (TB Alliance). TB Alliance is dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them. They are a 2018 Global Health Council Member. A Lingering Epidemic Tuberculosis…

Read More

The Local Path to Global Health Security

This article was originally published in Global Health NOW.  The article is around a WHA side-event organized by Global Health Council & partners. Global Health NOW has gathered thousands of subscribers worldwide who rely on it as a source for their global health news. The mobile-ready website globalhealthnow.org came online in March 2015, delivering more exclusive…

Read More

New Hope for Children with TB

This blog was written by the communications team at TB Alliance as part of Global Health Council’s Member Spotlight Series. Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them. TB Alliance is…

Read More

The Fight against TB: The Forgotten Battle

This post was written by Nicole Cho, Global Health Council (GHC) Intern. Tuberculosis (TB), the bacterial infection that mainly infects the lungs and is believed to have caused more deaths than famines and wars combined, is often seen as an ailment of the past. This conception seems true because sanitariums for consumption are no longer…

Read More

Fighting Big Diseases with Little Computers

This guest post was written by Jordan Coriza , Media Relations Manager and Content Editor, Management Sciences for Health (MSH). It was originally published on MSH’s website.   HOW HEALTH WORKERS USE TECHNOLOGY TO COMBAT ILLNESS Treatments for diseases like tuberculosis (TB) and HIV are lengthy and complex. Medications need to be taken regularly and for…

Read More

RESULTS' Legacy of TB Advocacy

Tuberculosis (TB) is one of the most pressing global health challenges of our time. Despite being preventable and curable, TB kills approximately 250,000 people a year. What’s more, curing TB requires a lengthy treatment period, which is often interrupted by poor access and adherence to therapy. Moreover, multi-drug resistant strains of TB are emerging at alarming rates in several regions across…

Read More